Sanjivani Paranteral Ltd Q2 FY26 earnings call summary

Earnings call of 19 Nov 2025, summarised by AI from the filing.

Q2 FY26 revenue ₹15.5 cr (down 14.5% YoY) on export disruptions; FY26 growth guided at least 10% with SPL Infusion revenue from Q3.

Key takeaways

1. FY26 guidance Revenue growth of at least 10% for FY26; SPL Infusion to start revenue from Q3 FY26.
2. Change SPL Infusion commercial batches started; revenue booking to begin in Q3 FY26.
3. Risk LatAm regulatory scrutiny and MENA approval delays slowed clearances and dispatches, impacting Q2 revenue.

Original filing on BSE

Sanjivani Paranteral Ltd earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (14 Aug 2026), Results press release (14 Aug 2026)
• Q4 FY26: Earnings call (15 May 2026), Results deck (14 May 2026)
• Q3 FY26: Earnings call (16 Feb 2026), Results deck (13 Jan 2026), Results press release (16 Feb 2026)
• Q2 FY26: Earnings call (19 Nov 2025), Results deck (18 Nov 2025), Results press release (15 Nov 2025)
• Q1 FY26: Earnings call (12 Aug 2025), Results deck (12 Aug 2025), Results press release (12 Aug 2025)
• Q4 FY25: Earnings call (27 May 2025), Results press release (27 May 2025)
• Q3 FY25: Results deck (27 Feb 2025)